Skip to main content
. Author manuscript; available in PMC: 2017 Mar 9.
Published in final edited form as: Cell Host Microbe. 2016 Feb 25;19(3):361–374. doi: 10.1016/j.chom.2016.02.001

Fig. 5. GM-CSF enhances killing of yeast by macrophages that is reversed by fungal DppIVA.

Fig. 5

(A) Yeast CFU (left) and percent killing (right) of yeast cultured for 24 hr with GM-CSF activated bone marrow derived Mϕs (BMDM). (B) Growth inhibition of yeast cultured with GM-CSF activated BMDM treated with DppIVA or diprotin A. (C) Lung CFU in Csf2ra−/− mice 7 days after infection with DppIVA RNAi yeast and adoptive transfer of wild-type vs. Csf2ra−/− peritoneal Mϕs. (See also Figure S3).